This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Solvay, H. Articles by Fenollar, J. Search for Related Content PubMed PubMed Citation Articles by Solvay, H. Articles by Fenollar, J. Social Bookmarking                         What's this?

Atherosclerosis and Cerebral Ischemic Attacks: Intakes of Cerebrography With Xenon133 Inhaled and Platelet Tests in the Diagnosis, Clinical and Therapeutic Monitoring; The Preventive Role of Dipyridamole

From the Free University Brussels, Fac. of Medicine-Department of Physiology, Brussels, Belgium

M. Kahn

From the Free University Brussels, Fac. of Medicine-Department of Physiology, Brussels, Belgium

P. Selosse

From the University Institute Antwerpen- Department of Neurosurgery, Antwerpen, Belgium

J. Carlier

From the Akademisch Ziekenhuis Antwerpen, Antwerpen, Belgium

M. Cloarec

University of Paris VI, CHU St-Anthony-medical polyclinic Tenon Hospital, Paris, France

J.P. Delwiche

University Clinics U.C.L. of Godinne, Laboratory of Functional Respiratory Exploration, Department of Pneumology, Godinne, Belgium

J. Fenollar

From the University of Valencia-Department of Internal Medicine, Department of Hematology and Medical Oncology, Valencia, Spain

A study of patients to develop the significance of the role of the blood plate lets in the recurrence of transient cerebral ischemic attacks in patients with cerebral atheromatous, develop the effectiveness of dipyridamole in the prophy lactic therapeutic regimen. In the group treated with dipyridamole, a 76.3% clinical improvement was recorded (mean increases of 11.2 ml/min. and 11.4 ml/min. of the cerebral hemispheric flows), 15.8% of cases stabilized (mean increases of 1.7 ml/min. and 1.2 ml/min.) and 7.9% failures (mean decreases of 10.4 ml/min. and 14.3 ml/min.) of these same flows. The cerebrography with xenon ¹³³ inhaled as well as the platelet tests used, constitute unfailing means of diagnosing and monitoring the clinical development.

Angiology, Vol. 35, No. 11, 709-718 (1984)
DOI: 10.1177/000331978403501104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Solvay, M. Kahn, S. Garreyn, M. Cloarec, R. Sneppe, E. Schram, and J.V. Fenollar Glucose and Erythrocyte ATP: Distinctive Effects of Dipyridamole and of Ticlopidine Angiology, November 1, 1987; 38(11): 815 - 824. [Abstract] [PDF]